Growth Metrics

Cme (CME) Asset Writedowns and Impairment (2018 - 2021)

Cme has reported Asset Writedowns and Impairment over the past 5 years, most recently at -$600000.0 for Q4 2021.

  • Quarterly Asset Writedowns and Impairment rose 45.45% to -$600000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$500000.0 through Sep 2021, down 101.82% year-over-year, with the annual reading at $26.3 million for FY2020, 56.96% down from the prior year.
  • Asset Writedowns and Impairment was -$600000.0 for Q4 2021 at Cme, down from $600000.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $39.5 million in Q3 2019 and troughed at -$9.5 million in Q4 2018.
  • The 4-year median for Asset Writedowns and Impairment is $2.7 million (2020), against an average of $8.7 million.
  • Biggest five-year swings in Asset Writedowns and Impairment: surged 315.79% in 2019 and later plummeted 101.27% in 2020.
  • Tracing CME's Asset Writedowns and Impairment over 4 years: stood at -$9.5 million in 2018, then skyrocketed by 515.79% to $39.5 million in 2019, then crashed by 102.78% to -$1.1 million in 2020, then surged by 45.45% to -$600000.0 in 2021.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at -$600000.0, $600000.0, and -$1.1 million for Q4 2021, Q3 2021, and Q4 2020 respectively.